Five-year outcomes after first- and second-generation drug-eluting stent implantation in all patients undergoing percutaneous coronary intervention
- 13 February 2019
- journal article
- research article
- Published by Elsevier BV in Journal of Cardiology
- Vol. 74 (2), 169-174
- https://doi.org/10.1016/j.jjcc.2019.01.012
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary StentsCirculation, 2012
- Stent Thrombosis With Everolimus-Eluting StentsCirculation: Cardiovascular Interventions, 2012
- Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug CoatingsCirculation, 2011
- A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: the PERSEUS Small Vessel trialEuroIntervention, 2011
- Pathological Findings at Bifurcation Lesions: The Impact of Flow Distribution on Atherosclerosis and Arterial Healing After Stent ImplantationJournal of the American College of Cardiology, 2010
- An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: A pooled analysis from the SPIRIT II and SPIRIT III trialsCatheterization and Cardiovascular Interventions, 2010
- Stent Thrombosis in SwedenCirculation: Cardiovascular Interventions, 2009
- Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)Vascular Health and Risk Management, 2008
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryThe New England Journal of Medicine, 2003